AWA
Aaron Wealth Advisors’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $866K | Buy |
22,553
+1,183
| +6% | +$45.4K | 0.09% | 149 |
|
|
2025
Q1 | $828K | Buy |
21,370
+1,084
| +5% | +$42K | 0.09% | 143 |
|
|
2024
Q4 | $686K | Sell |
20,286
-425
| -2% | -$14.4K | 0.08% | 154 |
|
|
2024
Q3 | $847K | Buy |
20,711
+2,103
| +11% | +$86K | 0.1% | 130 |
|
|
2024
Q2 | $716K | Buy |
18,608
+1,951
| +12% | +$75.1K | 0.1% | 133 |
|
|
2024
Q1 | $714K | Buy |
16,657
+4,446
| +36% | +$191K | 0.1% | 124 |
|
|
2023
Q4 | $453K | Buy |
12,211
+113
| +0.9% | +$4.19K | 0.08% | 143 |
|
|
2023
Q3 | $439K | Buy |
12,098
+637
| +6% | +$23.1K | 0.06% | 162 |
|
|
2023
Q2 | $408K | Buy |
11,461
+616
| +6% | +$22K | 0.05% | 176 |
|
|
2023
Q1 | $386K | Buy |
10,845
+886
| +9% | +$31.5K | 0.05% | 175 |
|
|
2022
Q4 | $350K | Buy |
+9,959
| New | +$350K | 0.05% | 179 |
|
|
2022
Q3 | – | Sell |
-13,318
| Closed | -$579K | – | 234 |
|
|
2022
Q2 | $579K | Sell |
13,318
-533,142
| -98% | -$23.2M | 0.15% | 94 |
|
|
2022
Q1 | $12.5M | Buy |
546,460
+533,507
| +4,119% | +$12.2M | 0.17% | 62 |
|
|
2021
Q4 | $571K | Buy |
12,953
+597
| +5% | +$26.3K | 0.16% | 87 |
|
|
2021
Q3 | $472K | Buy |
12,356
+1,628
| +15% | +$62.2K | 0.13% | 95 |
|
|
2021
Q2 | $427K | Buy |
10,728
+195
| +2% | +$7.76K | 0.14% | 102 |
|
|
2021
Q1 | $375K | Sell |
10,533
-516
| -5% | -$18.4K | 0.14% | 103 |
|
|
2020
Q4 | $406K | Buy |
+11,049
| New | +$406K | 0.15% | 89 |
|